Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy

BACKGROUND: Larger infarct size measured by creatine kinase (CK)-MB release is associated with higher mortality and has been used as an important surrogate endpoint in the evaluation of new treatments for ST-segment elevation myocardial infarction (STEMI). Traditional approaches to quantify infarct...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopes, Renato D, Lokhnygina, Yuliya, Hasselblad, Victor, Newby, Kristin L, Yow, Eric, Granger, Christopher B, Armstrong, Paul W, Hochman, Judith S, Mills, James S, Ruzyllo, Witold, Mahaffey, Kenneth W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662641/
https://www.ncbi.nlm.nih.gov/pubmed/23782531
http://dx.doi.org/10.1186/1745-6215-14-123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662641/
https://www.ncbi.nlm.nih.gov/pubmed/23782531
http://dx.doi.org/10.1186/1745-6215-14-123

Ejemplares similares